HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan-Jun Wen Selected Research

Neoplasm Antigens (Tumor Antigens)

7/2005[Screening tumor antigens of ovarian carcinoma by Western blot, immunoprecipitation, and mass spectrometry].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan-Jun Wen Research Topics

Disease

27Neoplasms (Cancer)
01/2017 - 02/2002
5Vesicular Stomatitis
03/2016 - 10/2004
5Carcinoma (Carcinomatosis)
02/2014 - 07/2005
3Necrosis
01/2017 - 06/2005
3Lung Neoplasms (Lung Cancer)
06/2005 - 10/2004
2Ovarian Neoplasms (Ovarian Cancer)
03/2016 - 02/2014
2Melanoma (Melanoma, Malignant)
11/2014 - 03/2006
2Adenocarcinoma of Lung
11/2012 - 10/2004
2Hepatocellular Carcinoma (Hepatoma)
11/2006 - 03/2006
2Lewis Lung Carcinoma
09/2005 - 10/2004
1Breast Neoplasms (Breast Cancer)
11/2014
1Lymphatic Metastasis
02/2014
1Adenocarcinoma
02/2014
1Colorectal Neoplasms (Colorectal Cancer)
12/2010
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2010
1Ascites
09/2009
1Pathologic Neovascularization
06/2008
1Fibrosarcoma
10/2007
1Colonic Neoplasms (Colon Cancer)
06/2005
1Neoplasm Metastasis (Metastasis)
11/2004

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
03/2016 - 09/2003
8VaccinesIBA
01/2017 - 02/2002
6Immunoglobulins (Immunoglobulin)IBA
03/2006 - 02/2002
5GemcitabineFDA Link
09/2005 - 10/2004
4AutoantibodiesIBA
03/2006 - 02/2002
4AntigensIBA
03/2006 - 02/2002
4Cisplatin (Platino)FDA LinkGeneric
06/2005 - 01/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 01/2005
3Liposomes (Liposome)IBA
09/2011 - 10/2007
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2005 - 09/2003
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2016 - 11/2012
2DNA (Deoxyribonucleic Acid)IBA
02/2014 - 09/2005
2EndostatinsIBA
09/2011 - 06/2005
2Antimicrobial PeptidesIBA
11/2009 - 06/2008
2Biological ProductsIBA
10/2008 - 01/2005
2LigandsIBA
06/2005 - 02/2002
2Combined VaccinesIBA
04/2005 - 01/2004
2EndoglinIBA
11/2004 - 07/2004
2AlginatesIBA
07/2004 - 09/2003
1Cancer VaccinesIBA
01/2017
1AntibodiesIBA
01/2017
1Folate Receptor 1IBA
03/2016
1CytokinesIBA
11/2014
1Paclitaxel (Taxol)FDA LinkGeneric
11/2014
1CC ChemokinesIBA
11/2014
1Chemokine CCL21IBA
11/2014
1Vascular Endothelial Growth Factor DIBA
02/2014
1Etoposide (VP 16)FDA LinkGeneric
11/2012
1Therapeutic UsesIBA
11/2012
1adenovirus receptorIBA
09/2011
1SurvivinIBA
12/2010
1Interleukin-4 (Interleukin 4)IBA
08/2010
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
08/2010
1Peptides (Polypeptides)IBA
11/2009
1hepatitis B virus X proteinIBA
09/2009
1CholesterolIBA
10/2008
1Matrix-MIBA
10/2008
11,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
10/2008
1Angiogenesis InhibitorsIBA
06/2008
1Trypan BlueFDA Link
11/2007
1Cytostatic AgentsIBA
11/2007
1FlavonoidsIBA
11/2007
1QuercetinIBA
11/2007
1Coloring Agents (Dyes)IBA
11/2007
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
11/2007
1Ethylene Glycol (Monoethylene Glycol)IBA
10/2007
1dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA
10/2007
1phosphatidylethanolamineIBA
10/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2006
1type IV collagen alpha3 chain (Goodpasture antigen)IBA
09/2005
1Neoplasm Antigens (Tumor Antigens)IBA
07/2005
1CXC ChemokinesIBA
06/2005
1Saline SolutionIBA
04/2005
1Chemotactic FactorsIBA
04/2005
1EnzymesIBA
04/2005
1Interferon-gamma (Interferon, gamma)IBA
04/2005
1Growth Factor ReceptorsIBA
09/2003
1AutoantigensIBA
09/2003
1GelatinIBA
02/2003
1Matrix Metalloproteinases (MMPs)IBA
02/2003
1GelatinasesIBA
02/2003
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2003
1IntegrinsIBA
02/2002
1Integrin beta3 (GPIIIa)IBA
02/2002

Therapy/Procedure

16Therapeutics
11/2014 - 02/2002
6Immunotherapy
10/2007 - 09/2003
4Drug Therapy (Chemotherapy)
06/2005 - 11/2004
2Biological Therapy
04/2005 - 11/2004
1Subcutaneous Injections
08/2010
1Intravenous Injections
10/2008